• Sun. Nov 27th, 2022

Here’s Why Novavax Stock Is Moving

ByHenry Khederian

Aug 3, 2022
Here's Why Novavax Stock Is Moving

Novavax, Inc. NVAX shares are trading higher in sympathy with Moderna Inc MRNA, which reported better-than-expected second-quarter results.

Quarterly revenue for Moderna was $4.75 billion compared to $4.34 million a year ago, beating the consensus of $4.07 billion.

Moderna has authorized an additional share repurchase program for $3 billion. The $3 billion repurchase program announced in February is continuing and currently has approximately $1 billion outstanding… Read More

See Also: Why Kintara Therapeutics Stock Is Skyrocketing Today

According to data from Benzinga Pro, Novavax has a 52-week high of $277.80 and a 52-week low of $34.88.



Image and article originally from www.benzinga.com. Read the original article here.